Mukhamadieva V.N., Shamsutdinova N.G., Abdulganieva D.I., Abdrakipov R.Z.,Mukhina R.G., Dyakova E.V., Sukhorukova E.V.
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases
|
№7 / 2023
|
Feyskhanova L.I., Abdrakipov R.Z., Vivolanets A.A., Akhmedieva D.V., Abdulganieva D.I.
Features of myocardial pathology in patients with extra-axial manifestations of ankylosing spondylitis
|
№7 / 2022
|
Dubinina T.V., Krichevskaya O.A.
Innovative strategy for diagnosis and treatment of axial spondyloarthritis
|
№2 / 2022
|
Fayrushina I.F., Lapshina S.A., Abdulganieva D.I.
From psoriatic arthritis to ankylosing spondylitis: pathway to the diagnosis
|
№3 / 2019
|
Belousova E.N., Protopopov M.S., Abdulganieva D.I.
Clinical features of gastrointestinal tractus damage in patients with ankylosing spondylitis
|
№1 / 2019
|
I.Z. Gaidukova, R.R. Samigulina, E.A. Vasilenko, O.V. Inamova, E.K. Gaidukova, E.A. Trophimov, V.I. Mazurov
Uveites as paradoxal reaction or nonefficacy of treatment in ankylosing spondylitis patients, getting inhibitors of alpha tumour necrosis factor
|
№4 / 2018
|